StockWatch
·
Q1 FY-2027 RESULTS · FCL

Fineotex Q1: acquisition drives consolidated PAT +93% to ₹48 Cr, but margins compress

PAT +92.6% YoY · revenue +174.8% · margins compressing

Q1 FY27 resultsFCLFINEOTEX CHEMICAL LTD.23 Jul 2026 · 3 min read
Revenue

₹376.63 Cr

+174.8% YoY

PAT (consolidated)

₹48.21 Cr

+92.6% YoY

Net margin

12.47%

-4.7pp YoY

EPS

₹0.41

Fineotex reported consolidated revenue of ₹376.63 Cr, up 174.8% YoY and 20% QoQ, with PAT of ₹48.21 Cr (+92.6% YoY, +10.1% QoQ) — but the surge is almost entirely inorganic. The newly-consolidated CrudeChem Technologies (CCT) oil & gas platform and twelve other subsidiaries contributed ₹310.83 Cr of revenue and ₹27.68 Cr of PAT (pre-elimination) this quarter. The core standalone (Indian textile-chemical) business actually shrank: standalone revenue was ₹85.15 Cr, down 13.3% YoY and 12.8% QoQ, with standalone PAT of ₹20.53 Cr up just 3.2%. Consolidated and standalone therefore tell materially different stories — the headline growth is scale bought through acquisition, not organic momentum in the legacy business.

The scoreboard

Q1 FY-2027 vs prior quarters

Consolidated P&L, ₹ Crore
Q1 FY-2027QoQYoY
Revenue₹376.63 Cr+20%+174.8%
Expenses₹321.97 Cr+17.1%+180.7%
PAT₹48.21 Cr+10.1%+92.6%
Net margin12.47%-1.1pp-4.7pp
EPS₹0.41+7.9%-81.2%

The mix shift into lower-margin oil & gas reset profitability: consolidated NPM fell to 12.5% from 17.1% a year ago (13.6% last quarter), and operational EBITDA margin was ~15.7% vs 18.4% YoY (though up from 13.9% QoQ, a sequential recovery). Owner-attributable PAT was ₹38.40 Cr, up 54.8% YoY — well below the +92.6% headline — because non-controlling interests took ₹9.81 Cr (≈20%) as CCT and the Malaysia units are not wholly owned. Reported EPS of ₹0.41 (vs ₹1.09 year-ago) reflects a roughly 5x expansion in share count (paid-up capital ₹116.45 Cr vs ₹22.92 Cr), so the per-share figure is not comparable YoY.

19.9727.5735.1742.7750.3747.4304-1005-1506-1807-2208-21
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹47.43, up 13.2% over the past month of trading.

₹ Cr
01835.9953.9920.13Q4 FY25rev ₹120 Cr25.03Q1 FY26rev ₹137 Cr26.08Q2 FY26rev ₹138 Cr30.12Q3 FY26rev ₹184 Cr43.79Q4 FY26rev ₹314 Cr48.21Q1 FY27rev ₹377 Cr
Quarterly consolidated PAT, ₹ Crore

For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 5 consecutive quarters; revenue is at a 6-quarter high.

What management guided (4 FY-2026 call)
Management provided a very optimistic outlook, projecting revenue to potentially reach INR 3,000 crores in 3-4 years, driven by organic growth and the strategic acquisition of CrudeChem Technologies (CCT). They anticipate CCT to contribute significantly, aiming for USD 200 million in revenue by FY28, with EBITDA margin

This quarter: met

Management's May concall guided toward ₹3,000 Cr revenue in 3-4 years, with CCT reaching USD 200m by FY28 and blended EBITDA of 18-20%; this quarter's ~₹1,500 Cr annualised run-rate and 130.8% consolidated volume growth track that thesis, though the current blended margin (~15.7%) still sits below the 18-20% target. No published street consensus exists for this ~₹4,500 Cr small-cap; the stock fell ~5% post-result as the market read the margin reset over the topline. Alongside the results, the board approved the 23rd AGM (Sep 11), a ₹0.05/share final dividend (record date Sep 4) and a fund-raising proposal.

  • W1

    Blended EBITDA margin trajectory toward management's 18-20% target — currently ~15.7% as oil & gas mix dilutes

  • W2

    Standalone core recovery — reversing the -13.3% YoY revenue decline (₹85.15 Cr) in the legacy textile-chemical business

  • W3

    Minority leakage — NCI absorbed ₹9.81 Cr (20%) of PAT; watch owner-share vs headline PAT gap as subsidiaries scale

Informational and educational content only. Not investment advice.